Fund Holdings — Sofinnova Investments, Inc.

Total Portfolio Value:
$2.32B
Total Bought:
$750.17M
Total Sold:
$519.07M
Net Transaction:
+$231.10M
Securities
▲▼
SharesValue
Q3 2025
▲▼
Q4 2025
▲▼
Change
▲▼
Q3 2025
▲▼
Q4 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Natera, Inc.(NTRA)1,550,2801,550,2800$249.55M$355.15M15.31%+$105.61M
Jazz Pharmaceuticals plcSHS USD(JAZZ)588,828959,860+371,032$77.61M$163.18M7.04%+$85.57M
AstraZeneca PLCADR(AZN)823,9331,632,334+808,401$63.21M$150.06M6.47%+$86.85M
Vera Therapeutics, Inc.CL A(VERA)2,793,9872,793,9870$81.19M$141.49M6.10%+$60.29M
Bristol-Myers Squibb Company(BMY)01,512,994+1,512,994$0$81.61M3.52%+$81.61M
United Therapeutics Corporation(UTHR)190,626157,641-32,985$79.91M$76.81M3.31%-$3.10M
Vertex Pharmaceuticals Incorporated(VRTX)117,875164,594+46,719$46.16M$74.62M3.22%+$28.46M
AbbVie Inc.(ABBV)150,966317,783+166,817$34.95M$72.61M3.13%+$37.66M
Intuitive Surgical, Inc.(ISRG)110,896126,968+16,072$49.60M$71.91M3.10%+$22.31M
Cogent Biosciences, Inc.(COGT)2,127,9411,973,625-154,316$30.56M$70.10M3.02%+$39.55M
Eli Lilly and Company(LLY)061,652+61,652$0$66.26M2.86%+$66.26M
Rapport Therapeutics, Inc.(RAPP)1,947,5791,904,408-43,171$57.84M$57.78M2.49%-$63.4K
BridgeBio Pharma, Inc.(BBIO)831,847720,448-111,399$43.21M$55.11M2.38%+$11.90M
Avidity Biosciences Inc875,925745,116-130,809$38.16M$53.75M2.32%+$15.58M
Dyne Therapeutics, Inc.(DYN)985,8282,254,161+1,268,333$12.47M$44.09M1.90%+$31.62M
BioMarin Pharmaceutical Inc.(BMRN)0697,133+697,133$0$41.43M1.79%+$41.43M
Apogee Therapeutics Inc565,417534,845-30,572$22.46M$40.37M1.74%+$17.91M
Cidara Therapeutics Inc54,197180,265+126,068$5.19M$39.82M1.72%+$34.63M
Praxis Precision Medicines, Inc.(PRAX)172,833125,722-47,111$9.16M$37.06M1.60%+$27.90M
Immatics N.V.SHS(IMTX)2,227,8373,435,542+1,207,705$18.98M$36.07M1.56%+$17.09M
Inhibrx Biosciences, Inc.(INBX)440,092454,657+14,565$14.82M$35.92M1.55%+$21.10M
Immunome, Inc.(IMNM)436,0511,618,477+1,182,426$5.11M$34.76M1.50%+$29.66M
ArriVent BioPharma, Inc.(AVBP)1,696,7521,696,7520$31.31M$34.14M1.47%+$2.83M
Glaukos Corporation(GKOS)312,994288,128-24,866$25.52M$32.53M1.40%+$7.01M
IDEAYA Biosciences, Inc.(IDYA)922,695885,121-37,574$25.11M$30.60M1.32%+$5.49M
BioAge Labs, Inc.(BIOA)2,293,7882,293,7880$13.49M$30.35M1.31%+$16.86M
Celcuity Inc.(CELC)253,375299,417+46,042$12.52M$29.86M1.29%+$17.35M
Rhythm Pharmaceuticals, Inc.(RYTM)246,966271,394+24,428$24.94M$29.05M1.25%+$4.11M
Centessa Pharmaceuticals PlcADS01,104,274+1,104,274$0$27.62M1.19%+$27.62M
Supernus Pharmaceuticals, Inc.(SUPN)377,066553,095+176,029$18.02M$27.49M1.19%+$9.47M
Insmed Incorporated(INSM)104,339156,801+52,462$15.03M$27.29M1.18%+$12.26M
Alcon Inc.(ALC)0332,520+332,520$0$26.21M1.13%+$26.21M
Arcus Biosciences, Inc.(RCUS)1,222,2631,096,705-125,558$16.62M$26.13M1.13%+$9.51M
DexCom, Inc.(DXCM)779,616378,219-401,397$52.46M$25.10M1.08%-$27.36M
Pharvaris N V
COM
739,876745,169+5,293$18.46M$20.68M0.89%+$2.22M
Nektar Therapeutics(NKTR)118,419438,630+320,211$6.74M$18.55M0.80%+$11.81M
Compass Therapeutics, Inc.(CMPX)2,028,8863,365,446+1,336,560$7.10M$18.07M0.78%+$10.97M
Roivant Sciences Ltd.SHS(ROIV)3,149,270734,582-2,414,688$47.65M$15.94M0.69%-$31.71M
Anaptysbio Inc254,268287,690+33,422$7.79M$13.95M0.60%+$6.16M
GE HealthCare Technologies Inc.(GEHC)151,085160,876+9,791$11.35M$13.20M0.57%+$1.85M
Edgewise Therapeutics, Inc.(EWTX)520,240437,819-82,421$8.44M$10.86M0.47%+$2.43M
Endeavour Silver Corp.(EXK)365,000101,443-263,557$19.97M$10.30M0.44%-$9.67M
Disc Medicine, Inc.(IRON)13,553111,010+97,457$895.6K$8.82M0.38%+$7.92M
Amylyx Pharmaceuticals, Inc.(AMLX)0527,099+527,099$0$6.37M0.27%+$6.37M
Masimo Corp046,201+46,201$0$6.01M0.26%+$6.01M
uniQure N.V.SHS(QURE)136,862176,513+39,651$7.99M$4.22M0.18%-$3.76M
Nextcure Inc222,654222,6540$1.30M$3.16M0.14%+$1.85M
Wave Life Sciences, Inc.SHS(WVE)170,943158,182-12,761$1.25M$2.69M0.12%+$1.44M
Xenon Pharmaceuticals Inc.(XENE)059,900+59,900$0$2.68M0.12%+$2.68M
Evommune, Inc.(EVMN)0153,320+153,320$0$2.62M0.11%+$2.62M
Axsome Therapeutics, Inc.(AXSM)393,49912,266-381,233$47.79M$2.24M0.10%-$45.55M
Establishment Labs Holdings Inc.(ESTA)10,78728,366+17,579$442.2K$2.07M0.09%+$1.63M
Ultragenyx Pharmaceutical Inc.(RARE)083,300+83,300$0$1.92M0.08%+$1.92M
Savara Inc.(SVRA)2,427,724304,770-2,122,954$8.67M$1.84M0.08%-$6.83M
Mirum Pharmaceuticals, Inc.(MIRM)023,100+23,100$0$1.82M0.08%+$1.82M
Acadia Pharmaceuticals Inc26,80065,567+38,767$571.9K$1.75M0.08%+$1.18M
Jade Biosciences Inc107,391107,3910$926.8K$1.66M0.07%+$730.3K
Bolt Biotherapeutics Inc137,721137,7210$732.7K$753.1K0.03%+$20.4K
Soleno Therapeutics Inc166,28112,414-153,867$11.24M$574.8K0.02%-$10.67M
ImageneBio, Inc.(IMA)31,88431,8840$259.9K$220.0K0.01%-$39.9K
Akero Therapeutics Inc473,6250-473,625$22.49M$0—-$22.49M
Boston Scientific Corporation(BSX)569,4270-569,427$55.59M$0—-$55.59M
Gilead Sciences, Inc.(GILD)1,252,3120-1,252,312$139.01M$0—-$139.01M
Merus N V166,7290-166,729$15.70M$0—-$15.70M
PTC Therapeutics, Inc.(PTCT)186,9320-186,932$11.47M$0—-$11.47M
Scholar Rock Holding Corporation(SRRK)31,4100-31,410$1.17M$0—-$1.17M
Page 1 of 1
Sofinnova Investments, Inc. — 13F Holdings — Q4 2025 | TickerTrail